Cargando…
A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, yet therapy is often hampered by immune-related adverse events (irAEs) which range from mild to severe life-threatening events. Musculoskeletal (MSK) irAEs leading to discontinuation of ICIs are uncommon but increasingl...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875374/ https://www.ncbi.nlm.nih.gov/pubmed/31781462 http://dx.doi.org/10.1155/2019/1326734 |